Preventive Cardiology
We collaborate with a diverse team of cardiovascular specialists to empower patients and their primary care providers to reduce risk factors for heart disease.
Proactive heart care
2025 Outcomes
Our preventive and advanced cardiac care programs involve a proactive team dedicated to comprehensive care. Preventive care is essential to Baylor Scott & White The Heart Hospital’s holistic approach to cardiovascular health. We offer the following clinics:
- Advanced Hypertension Clinic
- Advanced Lipid Clinic
- Cardio-genetics
- Cardio-obstetrics
- Cardio-oncology Center
- Chronic Chest Pain Clinic
- Coronary Microvascular
- Disease Clinic
- Women’s Heart Center
Accomplishments
Over the past year, preventive care programs for patients with atherosclerosis, endocrine issues and obesity have grown, with notable advancements for these patient populations
- Our Dallas location is among a few places in North Texas that offer lipoprotein apheresis as a treatment option for patients with familial hypercholesterolemia.
- After years of pioneering research in Dallas and Plano on a landmark treatment option for resistant hypertension, physicians on the medical staff in Plano, Dallas and Fort Worth offer the renal denervation procedure in collaboration with interventionalists.
- An inaugural study, Cardiovascular Disease Risk in South Asians in the Baylor Scott & White Health DILWALE Registry, was featured in The Journal of the American College of Cardiology Advances. The registry includes more than 31,000 individuals of South Asian ethnicity, the largest database of its kind in the U.S. This innovative work marks the beginning of an impactful journey, laying a solid foundation for future research and advancing cardiovascular care for South Asian populations.
- Lipoprotein bio-repository, a collaborative study with the National Institutes of Health, supported by a research grant from Novartis, will assay and statistically characterize the prevalence of Lp(a) plasma levels in patients with cardiovascular risk factors and cardiovascular disease, using selected demographic data. The study will investigate the relationships between Lp(a) plasma levels and the onset and progression of cardiovascular outcomes. As a registry, database and biospecimen repository, it will enable medical students, residents, fellows and faculty to ask questions in the future about biomarker assays related to the early recognition and treatment of heart and vascular diseases.
- The Women’s Heart Center champions focus on educating women about the “triple-testing” method, which estimates a woman’s 30-year cardiovascular risk through three easily accessible tests: high-sensitivity C-reactive protein, Lp(a) and LDL cholesterol.
“Fiscal year 2025 accomplishments include a broadened, curated team of national experts on the medical staff who practice in a setting where clinical medicine meets research and innovation. Our faculty have both clinical and academic expertise in these areas to help provide up-to-date and current recommendations to optimize cardiovascular health.”
Anandita Agarwala Kulkarni, MD, FACC
Regional Medical Director of Cardiovascular Disease Prevention and Cardio-obstetrics
Our heart team approach
This past year, cardiologists, endocrinologists, dietitians, nurses and cardiac exercise physiologists worked together to help prevent disease by developing individual treatment plans to optimize cardiometabolic health for patients with cardiovascular-kidney-metabolic syndrome.
Our Cardio-oncology Center, with programs in Dallas and Plano, focuses on preventing, detecting and managing potential cardiac harm that may occur from cancer treatments, including chemotherapy and radiation therapy. Our multidisciplinary team includes cardiology, hematology, oncology and radiation oncology specialists.
Quality awards 2025
Achievements placing us among the elite
Heart & Vascular Surgery
Denton: 3 Stars in 2 Categories
Denton
Previous
Next